Biopharmaceuticals Market By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) - Global Opportunity Analysis And Industry Forecast, 2018-2025
- Published Date: 2020-10-18
- Report ID: 3113
- Pages: 255
-
Format:
Biopharmaceuticals are drugs having a biological origin. These large and complex drugs, which often comprise heterogeneous mixtures, are produced using biotechnology and usually from genetically engineered cells. The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025.
The global biopharmaceuticals market is driven by various factors, such as surge in prevalence of chronic diseases and rapid increase in the elderly population globally. Similarly, increase in strategic collaboration among the biopharmaceuticals companies is also expected to boost the market. However, high costs of drug development and a stringent regulatory scenario with respect to biopharmaceuticals are anticipated to impede the market growth. Conversely, increase in purchasing power of emerging economics is anticipated to provide lucrative opportunities to the market players throughout the forecast period.
The global biopharmaceuticals market is segmented based on type, application, and region. Based on type, the market is divided into monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone, and others. By application, it is categorized into oncology, blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America Middle East and Africa (LAMEA).
KEY MARKET BENEFITS
The study provides an in-depth analysis of the global biopharmaceuticals market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report presents a quantitative analysis of the market from 2017 to 2025 to enable stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the market based on application assists in understanding the trends in the industry.
The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By product
Monoclonal antibody
Interferon
Insulin
Growth and coagulation factor
Erythropoietin
Vaccine
Hormone
Others
By application
Oncology
Blood disorder
Metabolic disease
Infectious disease
Cardiovascular disease
Neurological disease
Immunology
Others
By geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The list of key players operating in this market includes:
Abbott Laboratories
Amgen, Inc.
Biogen, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche, Ltd.
Johnson & Johnson
Merck & Co., Inc.
Novo Nordisk A/S
Pfizer, Inc.
Sanofi
The other players included in the value chain analysis (and not included in the report) include:
Bristol Myers Squibb Company
Bayer AG
Shire plc
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis, 2017
3.4. Clinical trials
3.5. Patent analysis, 2014-2018
3.5.1. Patent analysis, by year (2014-2018)
3.5.2. Patent analysis, by country
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in prevalence of chronic diseases
3.6.1.2. Rise in geriatric population and improvement in healthcare infrastructure
3.6.1.3. Increase in strategic acquisitions and collaborations
3.6.2. Restraints
3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Stringent regulatory scenario
3.6.3. Opportunity
3.6.3.1. Increase in purchasing power of emerging economics
CHAPTER 4: BIOPHARMACEUTICALS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Monoclonal Antibodies
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Interferons
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Insulin
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Growth and coagulation factors
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Erythropoietin
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Vaccines
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Hormones
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Other
4.9.1. Key market trends, growth factors and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
CHAPTER 5: BIOPHARMACEUTICALS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Blood Disorders
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Metabolic Diseases
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Infectious Diseases
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Cardiovascular Diseases
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Neurological Diseases
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
5.8. Immunology
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country
5.9. Other Applications
5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by country
CHAPTER 6: BIOPHARMACEUTICALS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America Biopharmaceuticals market size and forecast, by country
6.2.2.1. U.S. market size and forecast
6.2.2.1.1. U.S. Biopharmaceuticals market, by type
6.2.2.1.2. U.S. Biopharmaceuticals market, by application
6.2.2.2. Canada market size and forecast
6.2.2.2.1. Canada Biopharmaceuticals market, by type
6.2.2.2.2. Canada Biopharmaceuticals market, by application
6.2.2.3. Mexico market size and forecast
6.2.2.3.1. Mexico Biopharmaceuticals market, by type
6.2.2.3.2. Mexico Biopharmaceuticals market, by application
6.2.3. North America Biopharmaceuticals market size and forecast, by type
6.2.4. North America Biopharmaceuticals market size and forecast, by application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe Biopharmaceuticals market size and forecast, by country
6.3.2.1. Germany market size and forecast
6.3.2.1.1. Germany. Biopharmaceuticals market, by type
6.3.2.1.2. Germany Biopharmaceuticals market, by application
6.3.2.2. France market size and forecast
6.3.2.2.1. France Biopharmaceuticals market, by type
6.3.2.2.2. France Biopharmaceuticals market, by application
6.3.2.3. UK market size and forecast
6.3.2.3.1. UK Biopharmaceuticals market, by type
6.3.2.3.2. UK Biopharmaceuticals market, by application
6.3.2.4. Italy market size and forecast
6.3.2.4.1. Italy Biopharmaceuticals market, by type
6.3.2.4.2. Italy Biopharmaceuticals market, by application
6.3.2.5. Spain market size and forecast
6.3.2.5.1. Spain. Biopharmaceuticals market, by type
6.3.2.5.2. Spain Biopharmaceuticals market, by application
6.3.2.6. Rest of Europe market size and forecast
6.3.2.6.1. Rest of Europe Biopharmaceuticals market, by type
6.3.2.6.2. Rest of Europe Biopharmaceuticals market, by application
6.3.3. Europe Biopharmaceuticals market size and forecast, by type
6.3.4. Europe Biopharmaceuticals market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific Biopharmaceuticals market size and forecast, by country
6.4.2.1. Japan market size and forecast
6.4.2.1.1. Japan Biopharmaceuticals market, by type
6.4.2.1.2. Japan Biopharmaceuticals market, by application
6.4.2.2. China market size and forecast
6.4.2.2.1. China Biopharmaceuticals market, by type
6.4.2.2.2. China Biopharmaceuticals market, by application
6.4.2.3. India market size and forecast
6.4.2.3.1. India Biopharmaceuticals market, by type
6.4.2.3.2. India Biopharmaceuticals market, by application
6.4.2.4. Australia market size and forecast
6.4.2.4.1. Australia Biopharmaceuticals market, by type
6.4.2.4.2. Australia Biopharmaceuticals market, by application
6.4.2.5. South Korea market size and forecast
6.4.2.5.1. South Korea Biopharmaceuticals market, by type
6.4.2.5.2. South Korea Biopharmaceuticals market, by application
6.4.2.6. Rest of Asia-Pacific market size and forecast
6.4.2.6.1. Rest of Asia-Pacific Biopharmaceuticals market, by type
6.4.2.6.2. Rest of Asia-Pacific Biopharmaceuticals market, by application
6.4.3. Asia-Pacific Biopharmaceuticals market size and forecast, by type
6.4.4. Asia-Pacific Biopharmaceuticals market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. LAMEA Biopharmaceuticals market size and forecast, by country
6.5.2.1. Brazil market size and forecast
6.5.2.1.1. Brazil Biopharmaceuticals market, by type
6.5.2.1.2. Brazil Biopharmaceuticals market, by application
6.5.2.2. Saudi Arabia market size and forecast
6.5.2.2.1. Saudi Arabia. Biopharmaceuticals market, by type
6.5.2.2.2. Saudi Arabia Biopharmaceuticals market, by application
6.5.2.3. South Africa market size and forecast
6.5.2.3.1. South Africa Biopharmaceuticals market, by type
6.5.2.3.2. South Africa Biopharmaceuticals market, by application
6.5.2.4. Rest of LAMEA market size and forecast
6.5.2.4.1. Rest of LAMEA Biopharmaceuticals market, by type
6.5.2.4.2. Rest of LAMEA Biopharmaceuticals market, by application
6.5.3. LAMEA Biopharmaceuticals market size and forecast, by type
6.5.4. LAMEA Biopharmaceuticals market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Amgen Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Biogen Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Eli Lilly and Company
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. F. Hoffmann-La Roche Ltd.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Johnson & Johnson
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Merck & Co., Inc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Novo Nordisk A/S
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Pfizer Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Sanofi
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
